KYMR
HealthcareKymera Therapeutics, Inc.
$78.62+1.12 (+1.45%)
Prev Close
$77.50
Open
$78.18
High
$81.25
Low
$77.10
Volume
252.6K
Market Cap
$6.81B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Kymera Therapeutics, Inc. (KYMR) has been dominated by buying, with 3 insider purchases totaling $215.30M and 26 insider sales totaling $79.79M. The most recent insider transaction was by Chadwick Jeremy G (officer: Chief Operating Officer), who sold $2.15M worth of shares on Mar 11, 2026. Kymera Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $6.81B.
Buys (12M)
3
$215.30M
Sells (12M)
26
$79.79M
Net Activity
Net Buyer
$135.50M
Active Insiders
10
last 12 mo
KYMR Price Chart
KYMR Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026↗ | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 25,758 | $83.30 | $2.15M | 92,045 |
| Mar 4, 2026↗ | Booth Bruce | director | Sell | 163,732 | $90.13 | $14.76M | 3,902,670 |
| Mar 4, 2026↗ | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 11,916 | $86.54 | $1.03M | 79,219 |
| Mar 4, 2026↗ | Gollob Jared | officer: Chief Medical Officer | Sell | 21,016 | $87.24 | $1.83M | 126,132 |
| Mar 4, 2026↗ | Jacobs Bruce N. | officer: Chief Financial Officer | Sell | 24,942 | $87.50 | $2.18M | 243,020 |
| Feb 25, 2026↗ | Mainolfi Nello | director, officer: Chief Executive Officer | Sell | 30,000 | $90.26 | $2.71M | 676,431 |
| Feb 20, 2026↗ | Esposito Pamela | Director | Sell | 5,000 | $87.31 | $436.5K | 600 |
| Jan 20, 2026↗ | Esposito Pamela | director | Sell | 5,500 | $67.91 | $373.5K | 5,100 |
| Dec 31, 2025↗ | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $78.06 | $2.34M | 669,091 |
| Dec 17, 2025↗ | Esposito Pamela | Sell | 27,563 | $82.16 | $2.26M | 13,058 | |
| Dec 12, 2025↗ | Booth Bruce | Sell | 236,588 | $91.72 | $21.70M | 4,141,760 | |
| Dec 11, 2025↗ | BAKER BROS. ADVISORS LP | Buy | 2,005,813 | $86.00 | $172.50M | 7,955,920 | |
| Dec 8, 2025↗ | Albers Jeffrey W. | Sell | 5,000 | $89.76 | $448.8K | 2,252 | |
| Dec 8, 2025↗ | Gollob Jared | Chief Medical Officer | Sell | 49,307 | $88.67 | $4.37M | 145,540 |
| Dec 8, 2025↗ | Mainolfi Nello | Chief Executive Officer | Sell | 100,000 | $89.17 | $8.92M | 660,482 |
| Oct 29, 2025↗ | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $60.99 | $1.83M | 688,620 |
| Oct 15, 2025↗ | Gollob Jared | Chief Medical Officer | Sell | 59,576 | $61.42 | $3.66M | 140,304 |
| Oct 14, 2025↗ | Albers Jeffrey W. | Sell | 5,000 | $59.19 | $295.9K | 0 | |
| Oct 14, 2025↗ | Gollob Jared | Chief Medical Officer | Sell | 3,114 | $60.00 | $186.8K | 118,359 |
| Sep 17, 2025↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 79,220 | $50.00 | $3.96M | 227,409 |
| Sep 16, 2025↗ | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $49.00 | $1.47M | 660,482 |
| Jul 1, 2025↗ | BVF PARTNERS L P/IL | Director | Buy | 317,167 | $44.00 | $13.96M | 2,798,800 |
| Jun 30, 2025↗ | BAKER BROS. ADVISORS LP | Buy | 655,500 | $44.00 | $28.84M | 6,117,300 | |
| Jun 11, 2025↗ | Ridloff Elena | Sell | 4,500 | $50.00 | $225.0K | 0 | |
| Jun 3, 2025↗ | Albers Jeffrey W. | Sell | 6,349 | $49.00 | $311.1K | 0 | |
| Jun 3, 2025↗ | Esposito Pamela | Sell | 5,000 | $49.04 | $245.2K | 0 | |
| Jun 3, 2025↗ | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $49.00 | $1.47M | 660,482 |
| Jun 3, 2025↗ | Ridloff Elena | Sell | 12,000 | $46.10 | $553.2K | 4,800 | |
| May 23, 2025↗ | Chadwick Jeremy G | Chief Operating Officer | Sell | 2,575 | $29.30 | $75.4K | 66,420 |
| Mar 3, 2025↗ | Chadwick Jeremy G | Chief Operating Officer | Sell | 1,383 | $30.45 | $42.1K | 68,052 |
| Mar 3, 2025↗ | Chiniara Ellen | Chief Legal Officer | Sell | 2,241 | $30.45 | $68.2K | 80,493 |
| Mar 3, 2025↗ | Gollob Jared | Chief Medical Officer | Sell | 5,740 | $30.45 | $174.8K | 121,045 |
| Mar 3, 2025↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 7,035 | $30.45 | $214.2K | 203,167 |
| Jan 6, 2025↗ | Chiniara Ellen | Chief Legal Officer | Sell | 3,129 | $41.75 | $130.6K | 54,826 |
| Dec 2, 2024↗ | Esposito Pamela | Sell | 2,500 | $49.00 | $122.5K | 0 | |
| Sep 17, 2024↗ | Esposito Pamela | Sell | 13,500 | $48.28 | $651.8K | 7,150 | |
| Aug 26, 2024↗ | Albers Jeffrey W. | Sell | 5,000 | $49.10 | $245.5K | 0 | |
| Aug 22, 2024↗ | BAKER BROS. ADVISORS LP | Buy | 1 | $46.41 | $46.41 | 5,516,990 | |
| Aug 22, 2024↗ | BVF PARTNERS L P/IL | Director | Buy | 358,288 | $40.75 | $14.60M | 201,546 |
| Jul 16, 2024↗ | Gollob Jared | Chief Medical Officer | Sell | 39,600 | $45.53 | $1.80M | 105,604 |
| Jul 9, 2024↗ | Booth Bruce | Sell | 453,960 | $38.21 | $17.35M | 4,523,950 | |
| Jun 14, 2024↗ | Booth Bruce | Sell | 26,940 | $35.27 | $950.2K | 4,558,830 | |
| Jun 7, 2024↗ | Horobin Joanna | Sell | 8,500 | $32.99 | $280.4K | 6,313 | |
| May 23, 2024↗ | Chadwick Jeremy G | Chief Operating Officer | Sell | 2,575 | $34.99 | $90.1K | 44,183 |
| Mar 15, 2024↗ | Booth Bruce | Sell | 127,543 | $40.25 | $5.13M | 4,641,600 | |
| Mar 13, 2024↗ | Atlas Venture Fund X, L.P. | Sell | 353,357 | $42.20 | $14.91M | 4,930,930 | |
| Mar 13, 2024↗ | Booth Bruce | Sell | 353,357 | $42.20 | $14.91M | 4,930,930 | |
| Mar 4, 2024↗ | Gollob Jared | Chief Medical Officer | Sell | 3,344 | $41.86 | $140.0K | 97,062 |
| Mar 4, 2024↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 3,934 | $41.86 | $164.7K | 143,907 |
| Feb 29, 2024↗ | Gollob Jared | Chief Medical Officer | Sell | 400 | $45.00 | $18.0K | 74,709 |
| Feb 21, 2024↗ | Albers Jeffrey W. | Sell | 5,000 | $39.05 | $195.3K | 0 | |
| Feb 9, 2024↗ | Gollob Jared | Chief Medical Officer | Sell | 46,137 | $35.50 | $1.64M | 82,107 |
| Jan 23, 2024↗ | Albers Jeffrey W. | Sell | 10,000 | $30.05 | $300.5K | 0 | |
| Jan 9, 2024↗ | BVF PARTNERS L P/IL | Director | Buy | 979,014 | $25.25 | $24.72M | 550,425 |
| Jan 5, 2024↗ | Chiniara Ellen | Chief Legal Officer | Sell | 3,295 | $22.58 | $74.4K | 34,205 |
| Nov 6, 2023↗ | BVF PARTNERS L P/IL | Director | Buy | 414,105 | $12.80 | $5.30M | 2,656,190 |
| Mar 3, 2023↗ | Caughey Elaine | Chief Business Officer | Sell | 714 | $31.00 | $22.1K | 19,150 |
| Mar 3, 2023↗ | Gollob Jared | Chief Medical Officer | Sell | 1,298 | $31.00 | $40.2K | 75,006 |
| Mar 3, 2023↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 1,370 | $31.00 | $42.5K | 104,882 |
| Jan 13, 2023↗ | Atlas Venture Fund X, L.P. | 10% Owner | Sell | 126,474 | $30.22 | $3.82M | 5,045,240 |
| Jan 13, 2023↗ | Booth Bruce | Director | Sell | 126,474 | $30.22 | $3.82M | 5,045,240 |
| Jan 13, 2023↗ | BVF PARTNERS L P/IL | Director | Buy | 41,007 | $30.51 | $1.25M | 2,494,690 |
| Dec 16, 2022↗ | Atlas Venture Fund X, L.P. | 10% Owner | Sell | 382,244 | $31.36 | $11.99M | 5,252,740 |
| Dec 16, 2022↗ | Booth Bruce | Director | Sell | 382,244 | $31.36 | $11.99M | 5,252,740 |
| Nov 4, 2022↗ | Atlas Venture Fund X, L.P. | 10% Owner | Sell | 220,016 | $30.01 | $6.60M | 5,440,880 |
| Nov 4, 2022↗ | Booth Bruce | Director | Sell | 220,016 | $30.01 | $6.60M | 5,440,880 |
| Nov 1, 2022↗ | Atlas Venture Fund X, L.P. | 10% Owner | Sell | 288,702 | $30.26 | $8.74M | 5,691,880 |
| Nov 1, 2022↗ | Booth Bruce | Director | Sell | 288,702 | $30.26 | $8.74M | 5,691,880 |
| Aug 23, 2022↗ | BVF PARTNERS L P/IL | Director | Buy | 545,525 | $26.00 | $14.18M | 2,480,740 |
| May 31, 2022↗ | BVF PARTNERS L P/IL | Director | Buy | 289,426 | $14.34 | $4.15M | 2,195,700 |
| May 24, 2022↗ | BVF PARTNERS L P/IL | Director | Buy | 10,100 | $14.00 | $141.4K | 2,036,860 |
| May 9, 2022↗ | BVF PARTNERS L P/IL | Director | Buy | 250,000 | $19.46 | $4.87M | 2,030,980 |
| Jan 31, 2022↗ | BVF PARTNERS L P/IL | Director | Buy | 130,309 | $38.96 | $5.08M | 1,900,270 |
| Jan 26, 2022↗ | BVF PARTNERS L P/IL | Director | Buy | 272,767 | $37.76 | $10.30M | 1,822,140 |
| Jan 14, 2022↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 15,000 | $51.85 | $777.7K | 26,087 |
| Jan 12, 2022↗ | Mainolfi Nello | Chief Executive Officer | Sell | 48,000 | $53.31 | $2.56M | 487,179 |
| Dec 3, 2021↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 10,000 | $53.56 | $535.6K | 19,801 |
| Nov 2, 2021↗ | Gollob Jared | Chief Medical Officer | Sell | 57,493 | $62.16 | $3.57M | 59,767 |
| Oct 12, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 48,000 | $56.34 | $2.70M | 484,507 |
| Sep 3, 2021↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 10,000 | $60.12 | $601.2K | 8,756 |
| Aug 27, 2021↗ | Chesworth Richard | Chief Scientific Officer | Sell | 33,779 | $60.12 | $2.03M | 0 |
| Aug 19, 2021↗ | Chesworth Richard | Chief Scientific Officer | Sell | 54,000 | $50.37 | $2.72M | 45,191 |
| Aug 12, 2021↗ | ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sell | 242,133 | $61.00 | $14.77M | 0 |
| Aug 12, 2021↗ | Booth Bruce | Director | Sell | 242,133 | $61.00 | $14.77M | 0 |
| Aug 5, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 6,706 | $60.06 | $402.8K | 452,199 |
| Aug 2, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 30,415 | $60.25 | $1.83M | 454,023 |
| Jul 28, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 12,879 | $60.15 | $774.6K | 452,199 |
| Jul 9, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 48,000 | $49.70 | $2.39M | 482,969 |
| Jul 6, 2021↗ | BVF PARTNERS L P/IL | Director | Buy | 544,166 | $47.00 | $25.58M | 1,664,100 |
| Jun 11, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 23,009 | $51.38 | $1.18M | 425,105 |
| Jun 9, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 18,746 | $50.10 | $939.3K | 412,199 |
| Jun 4, 2021↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 10,000 | $46.87 | $468.7K | 11,494 |
| May 14, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 8,245 | $50.05 | $412.7K | 397,199 |
| Apr 26, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 14,407 | $40.23 | $579.6K | 397,199 |
| Apr 19, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 5,593 | $40.26 | $225.2K | 391,199 |
| Apr 12, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 48,000 | $33.62 | $1.61M | 381,104 |
| Mar 16, 2021↗ | ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sell | 229,350 | $56.50 | $12.96M | 0 |
| Mar 16, 2021↗ | Booth Bruce | Director | Sell | 229,350 | $56.50 | $12.96M | 0 |
| Mar 15, 2021↗ | Gollob Jared | Chief Medical Officer | Sell | 15,000 | $60.13 | $902.0K | 45,052 |
| Mar 15, 2021↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 10,000 | $60.15 | $601.5K | 0 |
| Mar 8, 2021↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 10,000 | $50.65 | $506.5K | 2,301 |
| Mar 5, 2021↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 20,000 | $44.78 | $895.6K | 13,119 |
KYMR Insider Buying Activity
The following table shows recent insider purchases of Kymera Therapeutics, Inc. (KYMR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025↗ | BAKER BROS. ADVISORS LP | Buy | 2,005,813 | $86.00 | $172.50M | 7,955,920 | |
| Jul 1, 2025↗ | BVF PARTNERS L P/IL | Director | Buy | 317,167 | $44.00 | $13.96M | 2,798,800 |
| Jun 30, 2025↗ | BAKER BROS. ADVISORS LP | Buy | 655,500 | $44.00 | $28.84M | 6,117,300 | |
| Aug 22, 2024↗ | BAKER BROS. ADVISORS LP | Buy | 1 | $46.41 | $46.41 | 5,516,990 | |
| Aug 22, 2024↗ | BVF PARTNERS L P/IL | Director | Buy | 358,288 | $40.75 | $14.60M | 201,546 |
| Jan 9, 2024↗ | BVF PARTNERS L P/IL | Director | Buy | 979,014 | $25.25 | $24.72M | 550,425 |
| Nov 6, 2023↗ | BVF PARTNERS L P/IL | Director | Buy | 414,105 | $12.80 | $5.30M | 2,656,190 |
| Jan 13, 2023↗ | BVF PARTNERS L P/IL | Director | Buy | 41,007 | $30.51 | $1.25M | 2,494,690 |
| Aug 23, 2022↗ | BVF PARTNERS L P/IL | Director | Buy | 545,525 | $26.00 | $14.18M | 2,480,740 |
| May 31, 2022↗ | BVF PARTNERS L P/IL | Director | Buy | 289,426 | $14.34 | $4.15M | 2,195,700 |
| May 24, 2022↗ | BVF PARTNERS L P/IL | Director | Buy | 10,100 | $14.00 | $141.4K | 2,036,860 |
| May 9, 2022↗ | BVF PARTNERS L P/IL | Director | Buy | 250,000 | $19.46 | $4.87M | 2,030,980 |
| Jan 31, 2022↗ | BVF PARTNERS L P/IL | Director | Buy | 130,309 | $38.96 | $5.08M | 1,900,270 |
| Jan 26, 2022↗ | BVF PARTNERS L P/IL | Director | Buy | 272,767 | $37.76 | $10.30M | 1,822,140 |
| Jul 6, 2021↗ | BVF PARTNERS L P/IL | Director | Buy | 544,166 | $47.00 | $25.58M | 1,664,100 |
KYMR Insider Selling Activity
The following table shows recent insider sales of Kymera Therapeutics, Inc. (KYMR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026↗ | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 25,758 | $83.30 | $2.15M | 92,045 |
| Mar 4, 2026↗ | Booth Bruce | director | Sell | 163,732 | $90.13 | $14.76M | 3,902,670 |
| Mar 4, 2026↗ | Chadwick Jeremy G | officer: Chief Operating Officer | Sell | 11,916 | $86.54 | $1.03M | 79,219 |
| Mar 4, 2026↗ | Gollob Jared | officer: Chief Medical Officer | Sell | 21,016 | $87.24 | $1.83M | 126,132 |
| Mar 4, 2026↗ | Jacobs Bruce N. | officer: Chief Financial Officer | Sell | 24,942 | $87.50 | $2.18M | 243,020 |
| Feb 25, 2026↗ | Mainolfi Nello | director, officer: Chief Executive Officer | Sell | 30,000 | $90.26 | $2.71M | 676,431 |
| Feb 20, 2026↗ | Esposito Pamela | Director | Sell | 5,000 | $87.31 | $436.5K | 600 |
| Jan 20, 2026↗ | Esposito Pamela | director | Sell | 5,500 | $67.91 | $373.5K | 5,100 |
| Dec 31, 2025↗ | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $78.06 | $2.34M | 669,091 |
| Dec 17, 2025↗ | Esposito Pamela | Sell | 27,563 | $82.16 | $2.26M | 13,058 | |
| Dec 12, 2025↗ | Booth Bruce | Sell | 236,588 | $91.72 | $21.70M | 4,141,760 | |
| Dec 8, 2025↗ | Albers Jeffrey W. | Sell | 5,000 | $89.76 | $448.8K | 2,252 | |
| Dec 8, 2025↗ | Gollob Jared | Chief Medical Officer | Sell | 49,307 | $88.67 | $4.37M | 145,540 |
| Dec 8, 2025↗ | Mainolfi Nello | Chief Executive Officer | Sell | 100,000 | $89.17 | $8.92M | 660,482 |
| Oct 29, 2025↗ | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $60.99 | $1.83M | 688,620 |
| Oct 15, 2025↗ | Gollob Jared | Chief Medical Officer | Sell | 59,576 | $61.42 | $3.66M | 140,304 |
| Oct 14, 2025↗ | Albers Jeffrey W. | Sell | 5,000 | $59.19 | $295.9K | 0 | |
| Oct 14, 2025↗ | Gollob Jared | Chief Medical Officer | Sell | 3,114 | $60.00 | $186.8K | 118,359 |
| Sep 17, 2025↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 79,220 | $50.00 | $3.96M | 227,409 |
| Sep 16, 2025↗ | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $49.00 | $1.47M | 660,482 |
| Jun 11, 2025↗ | Ridloff Elena | Sell | 4,500 | $50.00 | $225.0K | 0 | |
| Jun 3, 2025↗ | Albers Jeffrey W. | Sell | 6,349 | $49.00 | $311.1K | 0 | |
| Jun 3, 2025↗ | Esposito Pamela | Sell | 5,000 | $49.04 | $245.2K | 0 | |
| Jun 3, 2025↗ | Mainolfi Nello | Chief Executive Officer | Sell | 30,000 | $49.00 | $1.47M | 660,482 |
| Jun 3, 2025↗ | Ridloff Elena | Sell | 12,000 | $46.10 | $553.2K | 4,800 | |
| May 23, 2025↗ | Chadwick Jeremy G | Chief Operating Officer | Sell | 2,575 | $29.30 | $75.4K | 66,420 |
| Mar 3, 2025↗ | Chadwick Jeremy G | Chief Operating Officer | Sell | 1,383 | $30.45 | $42.1K | 68,052 |
| Mar 3, 2025↗ | Chiniara Ellen | Chief Legal Officer | Sell | 2,241 | $30.45 | $68.2K | 80,493 |
| Mar 3, 2025↗ | Gollob Jared | Chief Medical Officer | Sell | 5,740 | $30.45 | $174.8K | 121,045 |
| Mar 3, 2025↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 7,035 | $30.45 | $214.2K | 203,167 |
| Jan 6, 2025↗ | Chiniara Ellen | Chief Legal Officer | Sell | 3,129 | $41.75 | $130.6K | 54,826 |
| Dec 2, 2024↗ | Esposito Pamela | Sell | 2,500 | $49.00 | $122.5K | 0 | |
| Sep 17, 2024↗ | Esposito Pamela | Sell | 13,500 | $48.28 | $651.8K | 7,150 | |
| Aug 26, 2024↗ | Albers Jeffrey W. | Sell | 5,000 | $49.10 | $245.5K | 0 | |
| Jul 16, 2024↗ | Gollob Jared | Chief Medical Officer | Sell | 39,600 | $45.53 | $1.80M | 105,604 |
| Jul 9, 2024↗ | Booth Bruce | Sell | 453,960 | $38.21 | $17.35M | 4,523,950 | |
| Jun 14, 2024↗ | Booth Bruce | Sell | 26,940 | $35.27 | $950.2K | 4,558,830 | |
| Jun 7, 2024↗ | Horobin Joanna | Sell | 8,500 | $32.99 | $280.4K | 6,313 | |
| May 23, 2024↗ | Chadwick Jeremy G | Chief Operating Officer | Sell | 2,575 | $34.99 | $90.1K | 44,183 |
| Mar 15, 2024↗ | Booth Bruce | Sell | 127,543 | $40.25 | $5.13M | 4,641,600 | |
| Mar 13, 2024↗ | Atlas Venture Fund X, L.P. | Sell | 353,357 | $42.20 | $14.91M | 4,930,930 | |
| Mar 13, 2024↗ | Booth Bruce | Sell | 353,357 | $42.20 | $14.91M | 4,930,930 | |
| Mar 4, 2024↗ | Gollob Jared | Chief Medical Officer | Sell | 3,344 | $41.86 | $140.0K | 97,062 |
| Mar 4, 2024↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 3,934 | $41.86 | $164.7K | 143,907 |
| Feb 29, 2024↗ | Gollob Jared | Chief Medical Officer | Sell | 400 | $45.00 | $18.0K | 74,709 |
| Feb 21, 2024↗ | Albers Jeffrey W. | Sell | 5,000 | $39.05 | $195.3K | 0 | |
| Feb 9, 2024↗ | Gollob Jared | Chief Medical Officer | Sell | 46,137 | $35.50 | $1.64M | 82,107 |
| Jan 23, 2024↗ | Albers Jeffrey W. | Sell | 10,000 | $30.05 | $300.5K | 0 | |
| Jan 5, 2024↗ | Chiniara Ellen | Chief Legal Officer | Sell | 3,295 | $22.58 | $74.4K | 34,205 |
| Mar 3, 2023↗ | Caughey Elaine | Chief Business Officer | Sell | 714 | $31.00 | $22.1K | 19,150 |
| Mar 3, 2023↗ | Gollob Jared | Chief Medical Officer | Sell | 1,298 | $31.00 | $40.2K | 75,006 |
| Mar 3, 2023↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 1,370 | $31.00 | $42.5K | 104,882 |
| Jan 13, 2023↗ | Atlas Venture Fund X, L.P. | 10% Owner | Sell | 126,474 | $30.22 | $3.82M | 5,045,240 |
| Jan 13, 2023↗ | Booth Bruce | Director | Sell | 126,474 | $30.22 | $3.82M | 5,045,240 |
| Dec 16, 2022↗ | Atlas Venture Fund X, L.P. | 10% Owner | Sell | 382,244 | $31.36 | $11.99M | 5,252,740 |
| Dec 16, 2022↗ | Booth Bruce | Director | Sell | 382,244 | $31.36 | $11.99M | 5,252,740 |
| Nov 4, 2022↗ | Atlas Venture Fund X, L.P. | 10% Owner | Sell | 220,016 | $30.01 | $6.60M | 5,440,880 |
| Nov 4, 2022↗ | Booth Bruce | Director | Sell | 220,016 | $30.01 | $6.60M | 5,440,880 |
| Nov 1, 2022↗ | Atlas Venture Fund X, L.P. | 10% Owner | Sell | 288,702 | $30.26 | $8.74M | 5,691,880 |
| Nov 1, 2022↗ | Booth Bruce | Director | Sell | 288,702 | $30.26 | $8.74M | 5,691,880 |
| Jan 14, 2022↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 15,000 | $51.85 | $777.7K | 26,087 |
| Jan 12, 2022↗ | Mainolfi Nello | Chief Executive Officer | Sell | 48,000 | $53.31 | $2.56M | 487,179 |
| Dec 3, 2021↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 10,000 | $53.56 | $535.6K | 19,801 |
| Nov 2, 2021↗ | Gollob Jared | Chief Medical Officer | Sell | 57,493 | $62.16 | $3.57M | 59,767 |
| Oct 12, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 48,000 | $56.34 | $2.70M | 484,507 |
| Sep 3, 2021↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 10,000 | $60.12 | $601.2K | 8,756 |
| Aug 27, 2021↗ | Chesworth Richard | Chief Scientific Officer | Sell | 33,779 | $60.12 | $2.03M | 0 |
| Aug 19, 2021↗ | Chesworth Richard | Chief Scientific Officer | Sell | 54,000 | $50.37 | $2.72M | 45,191 |
| Aug 12, 2021↗ | ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sell | 242,133 | $61.00 | $14.77M | 0 |
| Aug 12, 2021↗ | Booth Bruce | Director | Sell | 242,133 | $61.00 | $14.77M | 0 |
| Aug 5, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 6,706 | $60.06 | $402.8K | 452,199 |
| Aug 2, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 30,415 | $60.25 | $1.83M | 454,023 |
| Jul 28, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 12,879 | $60.15 | $774.6K | 452,199 |
| Jul 9, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 48,000 | $49.70 | $2.39M | 482,969 |
| Jun 11, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 23,009 | $51.38 | $1.18M | 425,105 |
| Jun 9, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 18,746 | $50.10 | $939.3K | 412,199 |
| Jun 4, 2021↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 10,000 | $46.87 | $468.7K | 11,494 |
| May 14, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 8,245 | $50.05 | $412.7K | 397,199 |
| Apr 26, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 14,407 | $40.23 | $579.6K | 397,199 |
| Apr 19, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 5,593 | $40.26 | $225.2K | 391,199 |
| Apr 12, 2021↗ | Mainolfi Nello | Chief Executive Officer | Sell | 48,000 | $33.62 | $1.61M | 381,104 |
| Mar 16, 2021↗ | ATLAS VENTURE ASSOCIATES X, L.P. | 10% Owner | Sell | 229,350 | $56.50 | $12.96M | 0 |
| Mar 16, 2021↗ | Booth Bruce | Director | Sell | 229,350 | $56.50 | $12.96M | 0 |
| Mar 15, 2021↗ | Gollob Jared | Chief Medical Officer | Sell | 15,000 | $60.13 | $902.0K | 45,052 |
| Mar 15, 2021↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 10,000 | $60.15 | $601.5K | 0 |
| Mar 8, 2021↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 10,000 | $50.65 | $506.5K | 2,301 |
| Mar 5, 2021↗ | Jacobs Bruce N. | Chief Financial Officer | Sell | 20,000 | $44.78 | $895.6K | 13,119 |
KYMR Insiders
Similar Stocks to KYMR
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B